Oculis Holding AG (NAS:OCS) Stock News, Headlines & Updates
Oculis Holding AG Stock News from GuruFocus
- 1
Jun 10, 2024
Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Transform the Treatment Paradigm of Dry Eye Disease with a Precision Medicine Strategy
GlobeNewswire • 5:00am
Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Transform the Treatment Paradigm of Dry Eye Disease with a Precision Medicine Strategy
GlobeNewswire • 5:00am
Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Transform the Treatment Paradigm of Dry Eye Disease with a Precision Medicine Strategy
Marketwired • 4:00am
May 30, 2024
Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board
Marketwired • 3:00am
May 08, 2024
Oculis Reports Q1 2024 Financial Results and Provides Company Updates
Marketwired • 4:00pm
Oculis Announces Completion of Enrollment in Phase 2 Randomized Controlled ACUITY Trial with OCS-05 for Acute Optic Neuritis
Marketwired • 4:00pm
May 06, 2024
Oculis to Present at Bank of America Global Healthcare Conference
Marketwired • 6:00am
Apr 29, 2024
Oculis Publishes Invitation to the Annual General Meeting
Marketwired • 4:00pm
Apr 22, 2024
Oculis Announces Closing of Registered Direct Offering and Commencement of Trading on Nasdaq Iceland Main Market
Marketwired • 9:00am
Apr 11, 2024
Oculis Announces Completion of Oversubscribed $59 Million Registered Direct Offering and Subsequent Listing on Nasdaq Iceland Main Market
Marketwired • 8:00am
Apr 10, 2024
Oculis Strengthens its Executive Leadership Team with the Appointment of Snehal Shah, Pharm.D. as President of Research & Development
Marketwired • 6:00am
Apr 04, 2024
Oculis to Participate at Upcoming April Investor Conferences
Marketwired • 6:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news